Quantum BioPharma Ltd.
QNTM · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $6,083 | $3,859 | $6,911 | $6,328 |
| G&A Expenses | $9,310 | $13,205 | $15,981 | $23,370 |
| SG&A Expenses | $9,310 | $13,205 | $15,981 | $23,370 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $743 | $6,726 | $4,537 | $4,046 |
| Operating Expenses | $16,136 | $23,789 | $27,430 | $33,744 |
| Operating Income | -$16,136 | -$23,789 | -$27,430 | -$33,744 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $1,221 | $5,559 | $726 | -$194 |
| Pre-Tax Income | -$14,916 | -$18,231 | -$26,704 | -$33,938 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$14,203 | -$17,902 | -$23,607 | -$35,285 |
| % Margin | – | – | – | – |
| EPS | -12.49 | -29.39 | -39.62 | -65.63 |
| % Growth | 57.5% | 25.8% | 39.6% | – |
| EPS Diluted | -12.49 | -29.39 | -39.62 | -65.63 |
| Weighted Avg Shares Out | 1,137 | 609 | 596 | 538 |
| Weighted Avg Shares Out Dil | 1,137 | 609 | 596 | 538 |
| Supplemental Information | – | – | – | – |
| Interest Income | $573 | $786 | $368 | $1 |
| Interest Expense | $48 | $0 | $49 | $69 |
| Depreciation & Amortization | $491 | $2,506 | $4,537 | $4,046 |
| EBITDA | -$14,377 | -$15,724 | -$22,117 | -$29,823 |
| % Margin | – | – | – | – |